Miranda-3, t.z. "mirra"

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.E.000982.03.17
Date of registration and renewal:01.03.2017
Dosage form: & nbspTablets weighing 0.5 g.
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin
Composition: & nbspYeast autolysate, dried oregano extract, dry althea extract, dry licorice root extract, coenzyme Q10, microcrystalline cellulose, calcium stearate.
Scope: & nbspFor realization to the population as a biologically active food additive - a source of glycyrrhizic acid and coenzyme Q10.
Suggested Usage: & nbspAdults take 1 tablet 2 times a day with meals. Duration of admission is 1 month.
Contraindications:Individual intolerance to the components of the product, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry, dark place at a temperature of no higher than 25 ° C.
Research protocols:Expert conclusion of FGBUN "FIC of nutrition and biotechnology" No. 529 / E-38 / b-17 of 19.01.2017.
Recipient:Mirra-M, ZAOMirra-M, ZAO Russian Federation
Information update date: & nbsp14.03.2017
Instructions
Up